Physician profile
Seth Howard Glick
NPI 1689601874
$859.10
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $166 · 2021: $27.16.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $377.08 | 2019-2020 | |
| Coloplast Corp | $82.52 | 2019-2020 | |
| Pfizer INC. | $80.92 | 2019-2021 | |
| Antares Pharma, INC. | $58.42 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $41.11 | 2019 | |
| Endo Pharmaceuticals INC. | $33.58 | 2019 | |
| Rochester Medical Corporation | $31.25 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $28.45 | 2019 | |
| Cook Medical LLC | $28.11 | 2019 | |
| Ferring Pharmaceuticals INC. | $24.84 | 2019 | |
| Boston Scientific Corporation | $24.15 | 2019 | |
| Karl Storz Endoscopy-America | $23.23 | 2020 | |
| Janssen Biotech, INC. | $14.03 | 2019 | |
| Dentsply Ih INC. | $11.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Glick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.